Evaluation of the efficacy and tolerance of a new therapy, therapeutic monitoring, development of innovative tests for clinical diagnosis ... Clinical trial biology plays a crucial role in advancing medical research and improving the care and treatment of patients at all stages of the disease. For more than 15 years, we have been supporting companies in the pharmaceutical, biotechnology and in vitro diagnostic sectors by leveraging our expertise in medical biology.
Most of our clinical trial biology activity is carried out in collaboration with Cerba Research, a Cerba Healthcare Group entity specialized in clinical trials and present on five continents.
We also directly support industrial companies with their clinical trial projects, particularly in the fields of oncology and neurodegenerative diseases. Cerba remains a preferred partner for clinical trial biology thanks to:
• its high level of medical, scientific, and technical expertise
• its cutting-edge technological platform allowing access to the most innovative tests
• its extensive patient recruitment
• its large capacities in logistics, pre-analytical, analytical, and biological sample storage
• And finally, its extreme adaptability: Cerba supports you at all stages of the project in a personalized manner and according to all your specific needs (custom testing, custom storage, custom data reporting, custom method validation, etc.)
At Cerba Xpert, we support IVD manufacturers at every stage in the development of their devices. We offer unique access to collections of biological samples, both retrospective and prospective, essential for validating the performance of diagnostic tests. By combining this invaluable resource with access to reference diagnostic technologies and platforms and our in-depth knowledge of regulations, we help manufacturers to successfully complete their clinical and performance studies and obtain the IVDR CE mark.
